Abclonal Uk Limited PORT TALBOT


Abclonal Uk Limited is a private limited company registered at Unit 4, Baglan Bay Innovation Centre, Port Talbot SA12 7AX. Its total net worth is estimated to be roughly 0 pounds, and the fixed assets the company owns come to 0 pounds. Incorporated on 2021-11-12, this 2-year-old company is run by 1 director.
Director Jieyu Z., appointed on 01 January 2024.
The company is officially classified as "research and experimental development on biotechnology" (Standard Industrial Classification: 72110), "other business support service activities not elsewhere classified" (SIC code: 82990).
The last confirmation statement was sent on 2023-05-19 and the due date for the next filing is 2024-06-02.

Abclonal Uk Limited Address / Contact

Office Address Unit 4
Office Address2 Baglan Bay Innovation Centre
Town Port Talbot
Post code SA12 7AX
Country of origin United Kingdom

Company Information / Profile

Registration Number 13740530
Date of Incorporation Fri, 12th Nov 2021
Industry Research and experimental development on biotechnology
Industry Other business support service activities not elsewhere classified
End of financial Year 31st December
Company age 3 years old
Account next due date Sun, 12th Nov 2023 (169 days after)
Next confirmation statement due date Sun, 2nd Jun 2024 (2024-06-02)
Last confirmation statement dated Fri, 19th May 2023

Company staff

Jieyu Z.

Position: Director

Appointed: 01 January 2024

Xiao P.

Position: Director

Appointed: 12 November 2021

Resigned: 30 January 2024

People with significant control

The register of PSCs who own or have control over the company consists of 3 names. As we established, there is Wuhan Abclonal Biotechnology Co., Ltd from Dong Hu New Technology Development Zone, China. This PSC is categorised as "a private limited company", has 75,01-100% voting rights and has 75,01-100% shares. This PSC has 75,01-100% voting rights and has 75,01-100% shares. The second entity in the PSC register is Peggrem S. This PSC owns 75,01-100% shares. The third one is Xiao P., who also fulfils the Companies House requirements to be categorised as a PSC. This PSC owns 75,01-100% shares and has 75,01-100% voting rights.

Wuhan Abclonal Biotechnology Co., Ltd

Room 01, 4th Floor, Block 7, 1 Phase Wuhan Guang Gu International Biomedical Companies, 388 Gao Xin Second Road, Dong Hu New Technology Development Zone, Wuhan, China

Legal authority Companies Act 2006
Legal form Private Limited Company
Notified on 7 April 2022
Nature of control: 75,01-100% shares
75,01-100% voting rights
right to appoint and remove directors

Peggrem S.

Notified on 3 March 2022
Ceased on 7 April 2022
Nature of control: 75,01-100% shares

Xiao P.

Notified on 12 November 2021
Ceased on 3 March 2022
Nature of control: 75,01-100% shares
75,01-100% voting rights
right to appoint and remove directors

Annual reports financial information

Profit & Loss
Accounts Information Date 2022-12-31
Balance Sheet
Cash Bank On Hand144 872
Current Assets383 345
Debtors151 124
Other Debtors1 050
Property Plant Equipment52 118
Total Inventories87 349
Other
Audit Fees Expenses9 485
Accrued Liabilities Deferred Income11 350
Accumulated Depreciation Impairment Property Plant Equipment13 359
Additions Other Than Through Business Combinations Property Plant Equipment65 477
Administrative Expenses282 977
Amounts Owed To Group Undertakings311 365
Applicable Tax Rate19
Average Number Employees During Period5
Cash Cash Equivalents Cash Flow Value144 872
Comprehensive Income Expense-160 534
Cost Sales192 975
Creditors394 613
Depreciation Expense Property Plant Equipment13 359
Depreciation Rate Used For Property Plant Equipment20
Finance Lease Liabilities Present Value Total4 020
Gain Loss In Cash Flows From Change In Accrued Items10 985
Gain Loss In Cash Flows From Change In Creditors Trade Other Payables68 243
Gain Loss In Cash Flows From Change In Debtors Trade Other Receivables-151 124
Gain Loss In Cash Flows From Change In Inventories-87 349
Gain Loss On Non-financing Activities Due To Foreign Exchange Differences Recognised In Profit Or Loss-6 918
Gross Profit Loss122 930
Income Expense Recognised Directly In Equity200 000
Increase Decrease In Cash Cash Equivalents Before Foreign Exchange Differences Changes In Consolidation144 872
Increase Decrease In Net Debt From Cash Flows171 897
Increase From Depreciation Charge For Year Property Plant Equipment13 359
Interest Expense On Bank Overdrafts Bank Loans Similar Borrowings487
Interest Paid Classified As Operating Activities487
Interest Payable Similar Charges Finance Costs487
Issue Equity Instruments200 000
Net Cash Flows From Used In Financing Activities516 769
Net Cash Flows From Used In Investing Activities-65 477
Net Cash Flows From Used In Operating Activities-306 420
Net Cash Generated From Operations-305 933
Net Debt Funds171 897
Number Shares Issued Fully Paid50 000
Operating Profit Loss-160 047
Other Creditors10 623
Other Taxation Social Security Payable57 255
Par Value Share1
Payments Finance Lease Liabilities Classified As Financing Activities-5 404
Prepayments Accrued Income1 050
Proceeds From Issuing Shares200 000
Proceeds From Repayment Loans Advances To Group Undertakings Classified As Financing Activities311 365
Production Average Number Employees4
Profit Loss-160 534
Profit Loss On Ordinary Activities Before Tax-160 534
Property Plant Equipment Gross Cost65 477
Purchase Property Plant Equipment65 477
Raw Materials87 349
Revenue From Sale Goods315 905
Tax Expense Credit Applicable Tax Rate30 501
Tax Increase Decrease From Effect Capital Allowances Depreciation1 780
Tax Increase Decrease From Effect Expenses Not Deductible In Determining Taxable Profit Or Loss-1 295
Tax Increase Decrease From Other Short-term Timing Differences-40 773
Total Assets435 463
Total Liabilities435 463
Trade Debtors Trade Receivables149 024
Turnover Revenue315 905
Wages Salaries120 476
Director Remuneration40 200

Company filings

Filing category
Accounts Address Capital Confirmation statement Incorporation Officers Persons with significant control
Director's appointment was terminated on 2024-01-30
filed on: 30th, January 2024
Free Download (1 page)

Company search